Healthcare-associated infections
(HAIs) are the ones that are contracted by patients while they are receiving
treatment for another medical condition in a healthcare setting. Thus HAIs can
be acquired at any place where healthcare is delivered. HAIs are generally
caused by infectious agents, pathogens, fungi, bacteria, and viruses. The risk
factors associated with these infections are use of indwelling medical devices,
surgeries, injections, contaminated healthcare environment, communication of
diseases between workers and patients, and improper use of antibiotics.
HAIs are a major cause of mortality
and morbidity on a worldwide scale. Each year HAIs lead to thousands of deaths.
A majority of HAIs include conditions such as urinary tract infections,
surgical site infections, bloodstream infections, gastroenteritis, and
pneumonia. The overall HAI treatment market can be classified on the basis of
devices and pharmaceuticals used for HAI treatment. The major pharmaceuticals
used in HAI treatment are viral pharmaceuticals, bacterial pharmaceuticals, and
fungal pharmaceuticals. The major drug classes used in the pharmaceuticals
segment are B-Lactam Antibiotics, cephalosporins, quinolones, glycopeptides,
lincosamides, polypeptides, carbapenems, lipopeptides, penicillins, macrolides,
tuberculosis, etracyclines, sulfonamides, and other such formulations. The
medical devices segment can be further categorized into catheters and ventilation
devices and in-line sterile IV filtration.
To Read the Complete
Report with TOC Visit: http://www.marketresearchreports.biz/analysis-details/healthcare-associated-infections-hai-treatment-market-global-industry-analysis-size-share-growth-trends-and-forecast-2012-2018
The U.S. is the largest market for
HAI treatment pharmaceuticals and devices. In the U.S., each year more than 1.5
million patients contract HAI. Recently Partners for Patients had introduced a
USD 500 million grant to help hospitals and other healthcare providers to
reduce HAIs in the U.S. it is expected that if successful, this program will
save USD 50 billion of U.S. Medicare over the next ten years. The other markets
for HAI treatment devices and pharmaceuticals are Asia-Pacific, Europe, and the
Rest of the World. Some of the major players of this market include companies
such as Merck, Johnson & Johnson, GlaxoSmithKline, Sharklet Technologies,
Ondine Biomedical and some others.
This research report analyzes this
market depending on its market segments, major geographies, and current market
trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
This report provides comprehensive analysis
of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/169559
This report is a complete study of
current trends in the market, industry growth drivers, and restraints. It
provides market projections for the coming years. It includes analysis of
recent developments in technology, Porter’s five force model analysis and
detailed profiles of top industry players. The report also includes a review of
micro and macro factors essential for the existing market players and new
entrants along with detailed value chain analysis.
MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Email: sales@marketresearchreports.biz
Website: http://www.marketresearchreports.biz/
Blog: http://technaviomarketreports.blogspot.com/
No comments:
Post a Comment